Accessibility Statement

This statement covers hiracompound.com in full: the home page, the catalog, individual product pages, the cart and checkout, order status pages, published certificates of analysis, and every policy page linked in the footer.

The target standard is the Web Content Accessibility Guidelines (WCAG) 2.2 at Level AA. The site is currently assessed as partially conformant. Most success criteria are met. The ones that are not are listed under Known limitations rather than left unstated.

Hira Compounds is a sole proprietorship, independently owned and operated. Accessibility decisions, fixes and timelines are made by the owner, so a report goes directly to the person who can act on it.

The catalog lists research-use-only reference compounds supplied to qualified researchers and institutions for in-vitro laboratory research. Accessibility work changes how that information is presented, never what it says. Buyers must be 21 or older and are solely responsible for lawful handling.

The following are in place site-wide and are re-checked whenever a template changes.

Animation on this site is decorative. It is never used to carry meaning, and nothing on the site needs motion to be understood.

When a visitor turns on the reduced motion setting in Windows, macOS, iOS or Android, the site reads that preference and honors it. Scroll-triggered reveals, parallax, hover transforms, animated counters, sliding drawers and looping carousels are switched off. Content appears in its final state immediately instead of fading, sliding or scaling in.

Nothing on the site auto-plays for more than five seconds without a control to stop it. No content flashes more than three times per second, so the interface stays within the WCAG flash threshold.

Text is sized in relative units, so the site follows the default font size set in the browser or operating system instead of overriding it.

Text can be resized to 200 percent without loss of content or function. At 400 percent browser zoom the layout reflows to a single column and stays readable at a 320 CSS pixel viewport width, with no two-dimensional scrolling.

Line height, letter spacing, word spacing and paragraph spacing can be increased by user stylesheets or reading extensions without clipping text. Containers grow with their content rather than fixing a height in pixels.

Assay tables on certificate pages are the one exception to single-axis scrolling. On very narrow screens they scroll horizontally inside their own region. That region is keyboard focusable and scrollable with arrow keys, and the same values are repeated in the page text above it.

Manual testing is done on real assistive technology, not only in automated tools. The most recent full manual pass was completed in August 2026 on the combinations below.

These issues are known and are not yet fixed. Each one has a workaround and a target date. If one of them blocks you, use the contact details below and the information will be supplied another way at no cost.

Third-party content is the largest gap. Certificates of analysis are issued by Janoshik Analytical and are published as received so they can be verified unaltered at janoshik.com/verify. The source PDFs are not tagged for screen readers, and they are not edited, because editing would break verification.

Accessibility is checked on a fixed cycle rather than only after a complaint.

Automated scans with axe-core and Lighthouse run against the home page, a product page, a certificate page, the cart and the checkout at least once per quarter. Automated tools catch a minority of issues, so they are treated as a first pass, not a pass mark.

A manual keyboard and screen reader pass is run before any change to a shared template, before any new page type is published, and before any change to the checkout. New product pages are checked for heading order, alt text and contrast before they go live.

This statement is reviewed at least once a year, and immediately after any structural change to the site. It was last reviewed on September 2, 2026. The next scheduled review is on or before September 1, 2027.

When a barrier is found, it is logged with the page, the assistive technology involved, the WCAG criterion it fails and a target date. Anything that blocks a purchase or blocks access to handling and storage information is treated as urgent and fixed ahead of cosmetic issues.

If any part of hiracompound.com is hard to use, say so. Reports are read by the owner, and they are the fastest way an issue gets fixed.

Email support@hiracompound.com or call +1 (877) 940-3557, Monday to Friday, 9:00am to 6:00pm ET. Written reports can also be mailed to 3100 Warehime Rd, Manchester, MD 21102, United States.

Every report receives a substantive response within five business days of being received. That response will do one of three things: confirm the issue is fixed, give a target date for the fix, or set out an alternative way to get the same information or complete the same task in the meantime. If the fix will take longer than the target date, an updated date is sent rather than silence.

To make the reply faster and more useful, include what you can of the following. A partial report is still worth sending.

No visitor should have to fight the interface to get information or place an order. If a page does not work for you, everything on it is available another way.

By phone or email during business hours, the owner will describe a product, read out purity figures and the full assay values from a certificate of analysis, confirm a Janoshik verification key, quote current pricing and shipping, and place an order on your behalf.

Orders placed this way work the same as orders placed on the site. The order is created immediately and sits in Processing while payment is arranged. Payment is made by direct bank transfer, and the account details are sent in plain text by email or read out over the phone.

Order confirmations, payment instructions and shipping updates are sent as plain text email as well as HTML, so they stay readable in any mail client or screen reader.

If the reply you receive does not solve the problem, ask for it to be looked at again. Reply to the same email thread or call +1 (877) 940-3557 and say that you are asking for a second review.

A second review is answered in writing within a further five business days, with a plain explanation of what was found, what will change, and what will not. Where a fix is not possible in the short term, a specific alternative route to the same information or the same purchase is offered instead, at no additional cost and with no extra steps beyond what any other visitor faces.

This statement describes the current state of the site honestly, including where it falls short. It is written for visitors, not for a scoring exercise, and it is updated when the site changes rather than left to age.

The reference compounds listed on this site are for research use only. They are not drugs, supplements, cosmetics or food. They have not been evaluated by the FDA. They are sold strictly to qualified researchers and institutions for in-vitro laboratory research, and no medical, diagnostic or dosing guidance of any kind is provided.

Accessibility improvements never change what the site is allowed to say. Alternative formats, spoken descriptions and plain-text transcripts carry exactly the same information as the page they replace, with no additions.